Negative regulation of CDC42 expression and cell cycle progression by MIR-29a in breast cancer

15Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The inhibitory role of microRNA-29a (miR-29a) has been assessed in breast cancer cells. Herein, we analyze the underlying mechanisms of its role in cell cycle progression in breast cancer cells. We applied real-time polymerase chain reaction (PCR) to detect the expression of miR-29 in breast cancer cell lines. Then one of the cell lines, MDA-MB-453, was transfected with mimics of miR-29a. The cell cycle was analyzed by fluorescence-activated cell sorting after staining the cells with propidium iodide. Real-time PCR, luciferase assay and western blot were used together to verify the regulation of the predicted target, cell division cycle 42 (CDC42) by miR-29a. MiR-29s were decreased in our selected mammary cell lines, among which miR-29a was the dominant isoform. Overexpression of miR-29a caused cell cycle arrest at the G0/G1 phase. We further found that miR-29a could target the expression of CDC42, which is a small GTPase associated with cell cycle progression. We suggest that miR-29a exerts its tumor suppressor role in breast cancer cells partially by arresting the cell cycle through negative regulation of CDC42.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhang, M., Guo, W., Qian, J., & Wang, B. (2016). Negative regulation of CDC42 expression and cell cycle progression by MIR-29a in breast cancer. Open Medicine (Poland), 11(1), 78–82. https://doi.org/10.1515/med-2016-0015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free